Literature DB >> 12057614

Economic evaluation of strategies for the control and management of influenza in Europe.

P A Scuffham1, P A West.   

Abstract

We compared the cost-effectiveness of different strategies for the control and management of influenza for the elderly populations in three European countries (England and Wales, France, Germany). A "no intervention" scenario was compared with six control strategies: opportunistic vaccination (passive recruitment), comprehensive vaccination programmes (active recruitment), 4 weeks chemoprophylaxis course using neuraminidase inhibitors (NIs), 4 weeks chemoprophylaxis course using ion-channel inhibitors (ICIs), early treatment with NIs, and early treatment with ICIs. Vaccination strategies were the most cost-effective. Chemoprophylaxis strategies were highly expensive even under assumptions of optimal timing. Early treatment strategies with antivirals substantially increased demand for GP services and were more expensive than prevention through vaccination.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12057614     DOI: 10.1016/s0264-410x(02)00154-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  26 in total

1.  Vaccination with partial knowledge of external effectiveness.

Authors:  Charles F Manski
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205

Review 2.  Antiviral agents for influenza: a comparison of cost-effectiveness data.

Authors:  Larry D Lynd; Ron Goeree; Bernie J O'Brien
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany.

Authors:  Birgit Ehlken; Gabriele Ihorst; Barbara Lippert; Angela Rohwedder; Gudula Petersen; Martin Schumacher; Johannes Forster
Journal:  Eur J Pediatr       Date:  2005-06-18       Impact factor: 3.183

4.  Preventing and treating influenza.

Authors:  Klaus Stöhr
Journal:  BMJ       Date:  2003-06-07

5.  Strategies for Improving Influenza Vaccination Rates in Patients with Chronic Renal Disease.

Authors:  Kevin Schulte; Helen Schierke; Miguel Tamayo; Lutz Hager; Roland Engehausen; Matthias Raspe; Ralf-Harto Hübner; Georg Schlieper; Christoph Borzikowsky; Andreas Urbschat; Sven Auerswald; Ulrich Kunzendorf; Thorsten Feldkamp
Journal:  Dtsch Arztebl Int       Date:  2019-06-10       Impact factor: 5.594

Review 6.  Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group.

Authors:  Anthony T Newall; Heath Kelly; Stuart Harsley; Paul A Scuffham
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 7.  Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children.

Authors:  Vytautas Usonis; Ioana Anca; Francis André; Roman Chlibek; Inga Ivaskeviciene; Atanas Mangarov; Zsófia Mészner; Roman Prymula; Pavol Simurka; Eda Tamm; Goran Tesović
Journal:  BMC Infect Dis       Date:  2010-06-14       Impact factor: 3.090

8.  Identifying cost-effective dynamic policies to control epidemics.

Authors:  Reza Yaesoubi; Ted Cohen
Journal:  Stat Med       Date:  2016-07-24       Impact factor: 2.373

9.  Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons.

Authors:  P R Blank; M Schwenkglenks; T D Szucs
Journal:  Infection       Date:  2009-09-18       Impact factor: 3.553

10.  Pandemic influenza and healthcare demand in the Netherlands: scenario analysis.

Authors:  Marianne L L van Genugten; Marie-Louise A Heijnen; Johannes C Jager
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.